Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

University of Ulsan identifies new anticancer prodrugs

Aug. 13, 2010

Biotest updates development program for BT-062 in multiple myeloma

Aug. 12, 2010

ACT and Brown Cancer Center collaborate to identify cancer therapeutics

Aug. 12, 2010

Herceptin approved in Canada for HER2-positive stomach cancer

Aug. 12, 2010

Algeta begins phase I/IIa trial of Alpharadin/docetaxel combination in CRPC

Aug. 12, 2010

Hybrigenics presents new USP7 inhibitors

Aug. 12, 2010

Lentigen receives NIH grant to develop melanoma immunotherapy

Aug. 11, 2010

New alpha-mannosidase inhibitors identified by Emory University

Aug. 11, 2010

Daiichi Sankyo claims new Mdm2-p53 interaction inhibitors

Aug. 11, 2010

European researchers describe new Aurora kinase A inhibitors

Aug. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...